Literature DB >> 20688275

The importance of gene-centring microarray data.

Therese Sørlie, Eldrid Borgan, Simen Myhre, Hans Kristian Vollan, Hege Russnes, Xi Zhao, Gro Nilsen, Ole Christian Lingjaerde, Anne-Lise Børresen-Dale, Einar Rødland.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20688275     DOI： 10.1016/S1470-2045(10)70174-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  24 in total

Review 1.  Practical implications of gene-expression-based assays for breast oncologists.

Authors:  Aleix Prat; Matthew J Ellis; Charles M Perou
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

2.  A three-gene model to robustly identify breast cancer molecular subtypes.

Authors:  Benjamin Haibe-Kains; Christine Desmedt; Sherene Loi; Aedin C Culhane; Gianluca Bontempi; John Quackenbush; Christos Sotiriou
Journal:  J Natl Cancer Inst       Date:  2012-01-18       Impact factor: 13.506

Review 3.  How many etiological subtypes of breast cancer: two, three, four, or more?

Authors:  William F Anderson; Philip S Rosenberg; Aleix Prat; Charles M Perou; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2014-08-12       Impact factor: 13.506

Review 4.  Insight into the heterogeneity of breast cancer through next-generation sequencing.

Authors:  Hege G Russnes; Nicholas Navin; James Hicks; Anne-Lise Borresen-Dale
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

Review 5.  The breast cancer genome--a key for better oncology.

Authors:  Hans Kristian Moen Vollan; Carlos Caldas
Journal:  BMC Cancer       Date:  2011-11-30       Impact factor: 4.430

6.  A systematic review of datasets that can help elucidate relationships among gene expression, race, and immunohistochemistry-defined subtypes in breast cancer.

Authors:  Ifeanyichukwu O Nwosu; Stephen R Piccolo
Journal:  Cancer Biol Ther       Date:  2021-08-19       Impact factor: 4.875

7.  Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer.

Authors:  Luca Magnani; Alexander Stoeck; Xiaoyang Zhang; András Lánczky; Anne C Mirabella; Tian-Li Wang; Balázs Gyorffy; Mathieu Lupien
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

8.  Stromal genes add prognostic information to proliferation and histoclinical markers: a basis for the next generation of breast cancer gene signatures.

Authors:  Dwain Mefford; Joel Mefford
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

9.  Molecular subtyping for clinically defined breast cancer subgroups.

Authors:  Xi Zhao; Einar Andreas Rødland; Robert Tibshirani; Sylvia Plevritis
Journal:  Breast Cancer Res       Date:  2015-02-26       Impact factor: 6.466

10.  Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population.

Authors:  Chi-Cheng Huang; Shih-Hsin Tu; Heng-Hui Lien; Jaan-Yeh Jeng; Jung-Sen Liu; Ching-Shui Huang; Yih-Yiing Wu; Chih-Yi Liu; Liang-Chuan Lai; Eric Y Chuang
Journal:  J Transl Med       Date:  2012-09-19       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.